scholarly article | Q13442814 |
P356 | DOI | 10.1093/JAC/DKQ545 |
P698 | PubMed publication ID | 21393208 |
P2093 | author name string | Valentin Fuhrmann | |
Walter Jäger | |||
Brigitte Meyer | |||
Florian Thalhammer | |||
Judith M Leitner | |||
Michaela Böhmdorfer | |||
Clara Zuba | |||
Katrin Saria | |||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pharmacokinetics | Q323936 |
P304 | page(s) | 880-884 | |
P577 | publication date | 2011-01-22 | |
P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
P1476 | title | Multiple-dose pharmacokinetics of anidulafungin during continuous venovenous haemofiltration | |
P478 | volume | 66 |
Q41921220 | Anidulafungin dosing during CRRT: do not underestimate adsorption! |
Q38382954 | Caspofungin Population Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-Venous Haemofiltration or Haemodiafiltration |
Q53217028 | Current role of echinocandins in the management of invasive aspergillosis. |
Q54957028 | Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation. |
Q64926124 | Ex vivo Rezafungin Adsorption and Clearance During Continuous Renal Replacement Therapy. |
Q48192025 | Filter Adsorption of Anidulafungin to a Polysulfone-Based Hemofilter During CVVHD In Vitro |
Q26999448 | How to manage aspergillosis in non-neutropenic intensive care unit patients |
Q38462784 | Impact of special patient populations on the pharmacokinetics of echinocandins. |
Q38375996 | Micafungin Plasma Levels Are Not Affected by Continuous Renal Replacement Therapy: Experience in Critically Ill Patients |
Q42326553 | Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients |
Q38681635 | Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients |
Q37036404 | Pharmacokinetics of caspofungin in critically ill patients on continuous renal replacement therapy. |
Q57746174 | Pharmacological and Host Considerations Surrounding Dose Selection and Duration of Therapy with Echinocandins |
Q38153458 | The Eagle-like effect of echinocandins: what's in a name? |
Q37985070 | The use of antifungal therapy in neonatal intensive care. |
Q27012864 | Treatment with echinocandins during continuous renal replacement therapy |
Q87469389 | [Pharmacokinetic and pharmacodynamic aspects in antibiotic treatment] |
Search more.